Rhumbline Advisers lifted its stake in Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) by 9.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 36,384 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback